Paper · 30745814
A Pilot Study of Aberrant CpG Island Hypermethylation of SPRED1 in Acute Myeloloid Leukemia.
Sun J and 4 others. Int J Med Sci, 2019. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A Pilot Study of Aberrant CpG Island Hypermethylation of SPRED1 in Acute Myeloloid Leukemia. Papers, record 30745814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30745814
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Pilot Study of Aberrant CpG Island Hypermethylation of SPRED1 in Acute Myeloloid Leukemia.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intracellular Signaling Peptides and Proteins | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Membrane Proteins | Major topic |
| Adaptor Proteins, Signal Transducing | |
| Adolescent | |
| Adult | |
| Aged | |
| CpG Islands | |
| DNA Methylation | |
| Epigenesis, Genetic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Young Adult |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,493,923 | Spred is a Sprouty-related suppressor of Ras signalling. | Nature | 2001 | https://conductscience.org/library/papers/11493923 | PubMed |
| 2 | 12,154,405 | CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. | Oncogene | 2002 | https://conductscience.org/library/papers/12154405 | PubMed |
| 3 | 12,646,235 | Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/12646235 | PubMed |
| 4 | 14,744,114 | GeneNote: whole genome expression profiles in normal human tissues. | C R Biol | 2003 | https://conductscience.org/library/papers/14744114 | PubMed |
| 5 | 14,981,116 | Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP kinase activation. | J Exp Med | 2004 | https://conductscience.org/library/papers/14981116 | PubMed |
| 6 | 15,388,519 | Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. | Bioinformatics | 2005 | https://conductscience.org/library/papers/15388519 | PubMed |
| 7 | 15,952,895 | Eukaryotic cytosine methyltransferases. | Annu Rev Biochem | 2005 | https://conductscience.org/library/papers/15952895 | PubMed |
| 8 | 16,243,968 | Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16243968 | PubMed |
| 9 | 16,319,681 | C/EBPalpha and the pathophysiology of acute myeloid leukemia. | Curr Opin Hematol | 2006 | https://conductscience.org/library/papers/16319681 | PubMed |
| 10 | 16,652,141 | Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. | Oncogene | 2006 | https://conductscience.org/library/papers/16652141 | PubMed |
1 to 10 of 32
See all 32 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,094,606 | The role of SPRED1 mutation in melanoma. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41094606 | PubMed |
| 38,391,903 | Conditional Ablation of Spred1 and Spred2 in the Eye Lens Negatively Impacts Its Development and Growth. | Cells | 2024 | https://conductscience.org/library/papers/38391903 | PubMed |
| 35,359,401 | Methylation of SPRED1: A New Target in Acute Myeloid Leukemia. | Front Oncol | 2022 | https://conductscience.org/library/papers/35359401 | PubMed |
| 34,325,699 | Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. | BMC Pediatr | 2021 | https://conductscience.org/library/papers/34325699 | PubMed |
| 33,427,197 | Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. | Elife | 2021 | https://conductscience.org/library/papers/33427197 | PubMed |
| 32,851,895 | Progress in experimental research on SPRED protein family. | J Int Med Res | 2020 | https://conductscience.org/library/papers/32851895 | PubMed |
| 30,874,331 | The Sprouty/Spred family as tumor suppressors: Coming of age. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30874331 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CEBPA | 1,050 | PubTator's text mining | https://conductscience.org/library/genes/1050 | NCBI Gene |
| DNMT3A | 1,788 | PubTator's text mining | https://conductscience.org/library/genes/1788 | NCBI Gene |
| FLT3 | 2,322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| IDH1 | 3,417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| IDH2 | 3,418 | PubTator's text mining | https://conductscience.org/library/genes/3418 | NCBI Gene |
| KIT | 3,815 | PubTator's text mining | https://conductscience.org/library/genes/3815 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MAPK1 | 5,594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| NF1 | 4,763 | PubTator's text mining | https://conductscience.org/library/genes/4763 | NCBI Gene |
| NPM1 | 4,869 | PubTator's text mining | https://conductscience.org/library/genes/4869 | NCBI Gene |
1 to 10 of 16
See all 16 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30745814
GET https://conductscience.org/api/papers/v1/30745814/references?page=2